162 related articles for article (PubMed ID: 19101978)
21. α-D-mannose derivatives as models designed for selective inhibition of Golgi α-mannosidase II.
Poláková M; Šesták S; Lattová E; Petruš L; Mucha J; Tvaroška I; Kóňa J
Eur J Med Chem; 2011 Mar; 46(3):944-52. PubMed ID: 21295890
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a cDNA encoding a novel human Golgi alpha 1, 2-mannosidase (IC) involved in N-glycan biosynthesis.
Tremblay LO; Herscovics A
J Biol Chem; 2000 Oct; 275(41):31655-60. PubMed ID: 10915796
[TBL] [Abstract][Full Text] [Related]
23. Trichoderma reesei alpha-1,2-mannosidase: structural basis for the cleavage of four consecutive mannose residues.
Van Petegem F; Contreras H; Contreras R; Van Beeumen J
J Mol Biol; 2001 Sep; 312(1):157-65. PubMed ID: 11545593
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of alpha-mannosidase inhibitory activity of three deoxy derivatives of mannostatin A.
Ogawa S; Morikawa T
Bioorg Med Chem Lett; 1999 Jun; 9(11):1499-504. PubMed ID: 10386924
[TBL] [Abstract][Full Text] [Related]
25. Cyclopentanes from N-amino-glyconolactams. A synthesis of mannostatin A.
Hu G; Zimmermann M; Ramana CV; Vasella A
Chem Commun (Camb); 2003 Apr; (8):952-3. PubMed ID: 12744315
[TBL] [Abstract][Full Text] [Related]
26. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
Wen X; Yuan Y; Kuntz DA; Rose DR; Pinto BM
Biochemistry; 2005 May; 44(18):6729-37. PubMed ID: 15865418
[TBL] [Abstract][Full Text] [Related]
27. Carbasugar probes to explore the enzyme binding pocket at the anomeric position: application to the design of Golgi mannosidase II inhibitors.
Vinader MV; Afarinkia K
Curr Med Chem; 2013; 20(30):3797-801. PubMed ID: 23848537
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, enzymatic activity, and X-ray crystallography of an unusual class of amino acids.
Chen W; Kuntz DA; Hamlet T; Sim L; Rose DR; Mario Pinto B
Bioorg Med Chem; 2006 Dec; 14(24):8332-40. PubMed ID: 17010621
[TBL] [Abstract][Full Text] [Related]
29. Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals.
Moremen KW
Biochim Biophys Acta; 2002 Dec; 1573(3):225-35. PubMed ID: 12417404
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of tumor cell invasion in the Boyden chamber assay by a mannosidase inhibitor, mannostatin A.
Ochi Y; Atsumi S; Aoyagi T; Umezawa K
Anticancer Res; 1993; 13(5A):1421-4. PubMed ID: 8239514
[TBL] [Abstract][Full Text] [Related]
31. Golgi α-mannosidase: opposing structures of
Drogalin A; Monteiro LS; Alves MJ; Castro TG
J Biomol Struct Dyn; 2024 Mar; 42(5):2714-2725. PubMed ID: 37158092
[TBL] [Abstract][Full Text] [Related]
32. Substrate recognition and catalysis by GH47 α-mannosidases involved in Asn-linked glycan maturation in the mammalian secretory pathway.
Xiang Y; Karaveg K; Moremen KW
Proc Natl Acad Sci U S A; 2016 Dec; 113(49):E7890-E7899. PubMed ID: 27856750
[TBL] [Abstract][Full Text] [Related]
33. Combined inhibitor free-energy landscape and structural analysis reports on the mannosidase conformational coordinate.
Williams RJ; Iglesias-Fernández J; Stepper J; Jackson A; Thompson AJ; Lowe EC; White JM; Gilbert HJ; Rovira C; Davies GJ; Williams SJ
Angew Chem Int Ed Engl; 2014 Jan; 53(4):1087-91. PubMed ID: 24339341
[TBL] [Abstract][Full Text] [Related]
34. Molecular modeling studies of "flap up" mannosyl cation mimics.
Winkler DA
J Med Chem; 1996 Oct; 39(21):4332-4. PubMed ID: 8863810
[TBL] [Abstract][Full Text] [Related]
35. Novel tools for the study of class I alpha-mannosidases: a chromogenic substrate and a substrate-analog inhibitor.
Desmet T; Nerinckx W; Stals I; Callewaert N; Contreras R; Claeyssens M
Anal Biochem; 2002 Aug; 307(2):361-7. PubMed ID: 12202255
[TBL] [Abstract][Full Text] [Related]
36. In silico analysis of interaction pattern switching in ligandreceptor binding in Golgi α-mannosidase II induced by the protonated states of inhibitors.
Sladek V; Kóňa J; Tokiwa H
Phys Chem Chem Phys; 2017 May; 19(19):12527-12537. PubMed ID: 28470253
[TBL] [Abstract][Full Text] [Related]
37. Structure of Penicillium citrinum alpha 1,2-mannosidase reveals the basis for differences in specificity of the endoplasmic reticulum and Golgi class I enzymes.
Lobsanov YD; Vallée F; Imberty A; Yoshida T; Yip P; Herscovics A; Howell PL
J Biol Chem; 2002 Feb; 277(7):5620-30. PubMed ID: 11714724
[TBL] [Abstract][Full Text] [Related]
38. Enterococcus faecalis α1-2-mannosidase (EfMan-I): an efficient catalyst for glycoprotein N-glycan modification.
Li Y; Li R; Yu H; Sheng X; Wang J; Fisher AJ; Chen X
FEBS Lett; 2020 Feb; 594(3):439-451. PubMed ID: 31552675
[TBL] [Abstract][Full Text] [Related]
39. ER-resident protein 46 (ERp46) triggers the mannose-trimming activity of ER degradation-enhancing α-mannosidase-like protein 3 (EDEM3).
Yu S; Ito S; Wada I; Hosokawa N
J Biol Chem; 2018 Jul; 293(27):10663-10674. PubMed ID: 29784879
[TBL] [Abstract][Full Text] [Related]
40. Cyclic amidine sugars as transition-state analogue inhibitors of glycosidases: potent competitive inhibitors of mannosidases.
Heck MP; Vincent SP; Murray BW; Bellamy F; Wong CH; Mioskowski C
J Am Chem Soc; 2004 Feb; 126(7):1971-9. PubMed ID: 14971930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
